Shanghai Eyougene Biotechnology Development Co., Ltd. is a leading advanced chemical intermediates manufacturer in China, boasting three R&D centers and multiple production sites. The company specializes in custom synthesis and offers a wide range of products to various industries, including pharmaceutical, agriculture, and special industrial chemical sectors. Their facilities have been audited and approved by numerous customers, reflecting their commitment to quality and compliance. With a management team boasting over 20 years of experience, Shanghai Eyougene has positioned itself as a reliable and experienced player in the biotechnology and pharmaceutical industries.
Founded in 2016, the company recently secured a Series B investment on 12 January 2023 with participation from Huadian Fund and Lingdu Capital. This investment serves as a testament to the company's potential and the confidence that investors have in its future growth. As the company continues to expand its operations and strengthen its market presence, it is poised to make a significant impact on the biotechnology and pharmaceutical sectors in China and beyond.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | Unknown | 2 | Huadian Fund, Lingdu Capital | 12 Jan 2023 |
No recent news or press coverage available for Shanghai Eyougene Biotechnology Development Co., Ltd. .